The Invus Group's book
47 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Kailera Therapeutics (NAS: KLRA) | — | $1.5B | — | — | |
| Mirador Therapeutics | — | $1.0B | — | — | |
| Parabilis Medicines | Drug Discovery | $920.0M | — | — | |
| Jumbotail | — | $918.2M | — | — | |
| Best Egg | — | $800.0M | — | — | |
| Cardurion | Biotechnology | $760.0M | — | — | |
| Seaport Therapeutics | — | $740.0M | — | — | |
| VeraDermics (NYS: MANE) | Drug Discovery | $596.3M | — | — | |
| Bambusa Therapeutics | Drug Discovery | $555.0M | — | — | |
| CORXEL Pharmaceuticals | Drug Discovery | $474.9M | — | — | |
| + 37 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 47 recorded positions
- ·Watchlist + alerts for The Invus Group's activity
Create free account
No card required